Status:
RECRUITING
Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Conditions:
Cancer
Eligibility:
All Genders
Brief Summary
Multicentric prospective study with collection of biological samples as part of type II research
Eligibility Criteria
Inclusion Criteria:
- Patient with cancer who will start treatment anticancer (see cohorts).
- Patient information and signature of the consent form before any specific procedure for the study. The patient must be able and must be inclined to cooperate in the study procedures.
- Patient affiliated to a social security scheme or beneficiary of a similar scheme.
Exclusion Criteria:
- Pregnant or lactating woman
- Patient under guardianship or curatorship or deprived of liberty by a decision judicial or administrative or patient unable to give his consent.
Key Trial Info
Start Date :
January 22 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT04567446
Start Date
January 22 2018
End Date
December 1 2024
Last Update
June 12 2024
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Gustave Roussy
Villejuif, Val De Marne, France, 94800
2
Centre hospitalier du Pays d'Aix
Aix-en-Provence, France, 13616
3
Centre Pierre Curie
Beuvry, France, 62660
4
Clinique du Flandre
Coudekerque-Branche, France, 59210